ARTICLE | Company News
Advion, Eli Lilly deal
March 7, 2011 8:00 AM UTC
Eli Lilly will transition its drug discovery bioanalytical capability to Advion's Advion BioServices subsidiary. Advion will provide ADME and other early stage bioanalytical services. Financial terms ...